Skip to Content

Morgan Stanley Inst Growth A MSEGX

Analyst rating as of
NAV / 1-Day Return
74.08  /  3.32 %
Total Assets
13.2 Bil
Adj. Expense Ratio
0.840%
Expense Ratio
0.840%
Fee Level
Low
Longest Manager Tenure
16.11 years
Category
US Fund Large Growth
Investment Style
Large Growth
Min. Initial Investment
1,000
Status
Open
TTM Yield
0.00%
Turnover
87%
Premium

Morningstar’s Analysis

Will MSEGX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Morgan Stanley Comanager Takes Short Leave of Absence; Ratings Unchanged

Analyst Note

| |

Jason Yeung, a longtime member of Morgan Stanley's Counterpoint Global team, is taking a short leave of absence to join the White House coronavirus task force. Yeung is the team's most experienced healthcare analyst, though it has shored up expertise in that sector in recent years by adding an analyst and employing a couple of people with medical expertise on a consulting basis. While the length of his leave isn't clear, the team remains well staffed. The Morningstar Analyst Ratings and the High People Pillar ratings for the strategies Yeung comanages, including Morgan Stanley Institutional Growth MSEGX, Morgan Stanley Institutional Advantage MAPPX, and Morgan Stanley Institutional Discovery MACGX, remain intact.

Unlock our full analysis with Morningstar Premium